71777-70-3

Basic information

• Product Name: 4-Ethoxy-2-pyridinecarboxylic acid ethyl ester
• Synonyms: 4-Ethoxy-2-pyridinecarboxylic acid ethyl ester;Ethyl 4-ethoxy-2-pyridinecarboxylate;Ethyl 4-ethoxypicolinate;4-Ethoxypyridine-2-carboxylic acid ethyl ester
• CAS NO: 71777-70-3
• Molecular Formula: C₁₀H₁₃NO₃
• Molecular Weight: 195.217
• Mol File: 71777-70-3.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 309 °C at 760 mmHg
• Flash Point: 140.7 °C
• Appearance: /
• Density: 1.099
• Refractive Index: 1.498
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 4-Ethoxy-2-pyridinecarboxylic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Ethoxy-2-pyridinecarboxylic acid ethyl ester(71777-70-3)
• EPA Substance Registry System: 4-Ethoxy-2-pyridinecarboxylic acid ethyl ester(71777-70-3)

Safety Data

• Hazardous Substances Data: 71777-70-3(Hazardous Substances Data)

Usage

General Description

4-Ethoxy-2-pyridinecarboxylic acid ethyl ester is a chemical compound frequently mentioned in the field of organic chemistry. Its molecular formula is C11H13NO3 and its systematic name is Ethyl 4-ethoxy-2-pyridinecarboxylate. The compound belongs to the family of Pyridinecarboxylic Acids and derivatives. These are compounds containing a pyridine ring bearing a carboxylic acid group or its derivatives. 4-Ethoxy-2-pyridinecarboxylic acid ethyl ester is mainly used in scientific and industrial applications. However, information on its specific uses, properties, or hazards remains limited.

InChI:InChI=1/C10H13NO3/c1-3-13-8-5-6-11-9(7-8)10(12)14-4-2/h5-7H,3-4H2,1-2H3

Upstream product

• 5470-22-4 4-chloropicolinic acid 
• 64-17-5 ethanol 
• 19235-89-3 4-chloro-pyridine-2-carbonitrile 
• 53750-66-6 4-chloro-pyridine-2-carbonyl chloride 

Relevant articles and documents

TETRAHYDROISOQUINOLINE DERIVED PRMT5-INHIBITORS

A compound of formula I wherein: n is 1 or 2: p is 0 or 1; R1 is optionally one or more halo or methyl groups; R2a and R2b are independently selected from the group consisting of: (i) F; (ii) H; (iii) Me; and (iv) CH2OH; R2c and R2d are independently selected from the group consisting of: (i) F; (ii) H; (iii) Me; and (iv) CH2OH; R3a and R3b are independently selected from H and Me; R4 is either H or Me; R5 is either H or Me; R6a and R6b are independently selected from H and Me; A is either (i) optionally substituted phenyl; (ii) optionally substituted naphthyl; or (iii) optionally substituted C5-12 heteroaryl.

SUBSTITUTED PYRIDINE COMPOUNDS AS CRAC MODULATORS

The present invention relates to compounds described herein Formula (I) and pharmaceutical acceptable salts thereof, which modulate the activity of calcium release- activated calcium (CRAC) channel. The invention also describes the compounds of Formula (I)and pharmaceutical compositions containing such compounds thereof for treating, managing, and/or lessening the severity of diseases, disorders, syndromes or conditions associated with the modulation of calcium release-activated calcium (CRAC) channel.

Use of metal complex compounds as catalysts for oxidation using molecular oxygen or air

Use, as a catalyst for oxidation reactions using molecular oxygen and/or air, of at least one metal complex compound of formula (1) wherein Me is manganese, titanium, iron, cobalt, nickel or copper, X is a coordinating or bridging radical, n and m are each independently of the other an integer having a value of from 1 to 8, p is an integer having a value of from 0 to 32, z is the charge of the metal complex, Y is a counter-ion, q=z/(charge of Y), and L is a ligand of formula (2) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 are each independently of the others hydrogen; unsubstituted or substituted C1-C18alkyl or aryl; cyano; halogen; nitro; —COOR12 or —SO3R12 wherein R12 is in each case hydrogen, a cation or unsubstituted or substituted C1-C18alkyl or aryl; —SR13, —SO2R13 or —OR13 wherein R13 is in each case hydrogen or unsubstituted or substituted C1-C18alkyl or aryl; —NR14R15; —(C1-C6alkylene)-NR14R15; —N(+)R14R15R16; —(C1-C6alkylene)-N(+)R14R15R16; —N(R13)—(C1-C6alkylene)-NR14R15; —N[(C1-C6alkylene)-NR14R15]2; —N(R13)—(C1-C6alkylene)-N(+)R14R15R16; —N[(C1-C6alkylene)-N(+)R14R15R16]2; —N(R13)—N—R14R15 or —N(R13)N″R14R15R16, wherein R13 is as defined above and R14, R15 and R16 are each independently of the other(s) hydrogen or unsubstituted or substituted C1-C18alkyl or aryl, or R14 and R15, together with the nitrogen atom linking them, form an unsubstituted or substituted 5-, 6- or 7-membered ring which may contain further hetero atoms. [in-line-formulae][LnMemXp]zYq??(1) [/in-line-formulae]